In particular, IL8 expression in the prostate correlates positively with tumor progression and cell dedifferentiation (Lee et al. 2004), and its levels are higher in the serum of patients with metastatic PCa (Murphy et al. 2005). The gene discussed is CXCL8; the disease is neoplasm.